Edition:
United Kingdom

Ibnsina Pharma Co (ISPH.CA)

ISPH.CA on The Egyptian Exchange

10.40EGP
16 Sep 2019
Change (% chg)

-- (--)
Prev Close
£10.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
812,155
52-wk High
£11.97
52-wk Low
£6.52

Latest Key Developments (Source: Significant Developments)

Egyptian Exchange Says EBRD Reduces Stake In Ibnsina Pharma To 8.71%
Sunday, 8 Sep 2019 

Sept 8 (Reuters) - EGYPTIAN EXCHANGE::THE EUROPEAN BANK FOR RECONSTRUCTION AND DEVELOPMENT SELLS 11.4 MILLION SHARES IN IBNSINA PHARMA.TRANSACTION GROSS VALUE EGP 110.8 MILLION.THE EUROPEAN BANK FOR RECONSTRUCTION AND DEVELOPMENT REDUCES STAKE IN IBNSINA PHARMA TO 8.71% FROM 10.10%.  Full Article

Egyptian Exchange Says Ibnsina Pharma Shares Block Traded For EGP 26.8 Mln
Monday, 3 Jun 2019 

June 3 (Reuters) - EGYPTIAN EXCHANGE::SAYS IBNSINA PHARMA CO'S 2.3 MILLION SHARES BLOCK TRADED FOR TOTAL VALUE OF EGP 26.8 MILLION.  Full Article

Egypt's Ibnsina Pharma Q1 Profit Rises
Sunday, 12 May 2019 

May 12 (Reuters) - IBNSINA PHARMA CO ::Q1 NET PROFIT EGP 41 MILLION VERSUS EGP 28 MILLION YEAR AGO.Q1 SALES EGP 3.81 BILLION VERSUS EGP 2.96 BILLION YEAR AGO.  Full Article

Ibnsina Pharma Shareholders Approve Capital Increase
Sunday, 21 Apr 2019 

April 21 (Reuters) - IBNSINA PHARMA ::SHAREHOLDERS APPROVE ISSUED CAPITAL INCREASE TO EGP 205 MILLION FROM EGP 180.5 MILLION THROUGH BONUS SHARE ISSUE.  Full Article

Egypt's Ibnsina Pharma Board Proposes FY Dividend
Thursday, 7 Mar 2019 

March 7 (Reuters) - IBNSINA PHARMA CO ::BOARD PROPOSES CASH DIVIDEND OF 7 QIRSH PER SHARE FOR YEAR 2018.BOARD PROPOSES FY STOCK DIVIDEND OF 0.1357340720 BONUS SHARE FOR EVERY ONE SHARE.  Full Article

Egypt's Ibnsina Pharma FY Profit Rises
Thursday, 7 Mar 2019 

March 7 (Reuters) - IBNSINA PHARMA CO ::FY NET PROFIT EGP 262.5 MILLION VERSUS EGP 170.1 MILLION YEAR AGO.FY REVENUE EGP 13.68 BILLION VERSUS EGP 9.82 BILLION YEAR AGO.  Full Article

Egypt's Ibnsina Says Appeal Court Issues Ruling Reducing Fine Imposed On Executives
Wednesday, 20 Feb 2019 

Feb 20 (Reuters) - IBNSINA PHARMA CO ::APPEALS COURT ISSUED A RULING REDUCING FINE IMPOSED ON EXECUTIVES FROM IBNSINA PHARMA TO EGP 160 MILLION, DOWN FROM AN ORIGINAL EGP 2.04 BILLION .ON FEBRUARY 28, 2018 A COURT HAD IMPOSED FINE ON CO'S EXECUTIVES.  Full Article

Egypt's Ibnsina Pharma Q3 Profit Rises
Sunday, 11 Nov 2018 

Nov 11 (Reuters) - IBNSINA PHARMA CO ::Q3 NET PROFIT EGP 113.2 MILLION VERSUS EGP 89.4 MILLION YEAR AGO.Q3 REVENUE EGP 3.58 BILLION VERSUS EGP 2.70 BILLION YEAR AGO.NINE-MONTH NET PROFIT EGP 188.3 MILLION VERSUS EGP 143.1 MILLION YEAR AGO.  Full Article

Ibnsina Pharma Q1 Profit Rises
Monday, 14 May 2018 

May 14 (Reuters) - IBNSINA PHARMA CO ::Q1 NET PROFIT EGP 28 MILLION VERSUS EGP 19.1 MILLION YEAR AGO.Q1 REVENUE EGP 2.96 BILLION VERSUS EGP 1.95 BILLION YEAR AGO.  Full Article

Egypt's Ibnsina Pharma Q4 Profit Rises
Sunday, 4 Mar 2018 

March 4 (Reuters) - IBNSINA PHARMA CO ::Q4 NET PROFIT EGP 49.1 MILLION VERSUS EGP 20.1 MILLION YEAR AGO.Q4 NET REVENUE EGP 2.87 BILLION VERSUS EGP 2.20 BILLION YEAR AGO.FY NET PROFIT EGP 192.1 MILLION VERSUS EGP 101.7‍​ MILLION YEAR AGO.FY NET REVENUE EGP 9.59 BILLION VERSUS EGP 7.21 BILLION YEAR AGO.  Full Article